TEMPLATE

Leaders in Learning: Publications of Faculty & Staff

Oncology 2003-2004

ASH, R.

Lock, M., E. Wong, E. Paradis, V. Moiseenko, G. Rodrigues, D. D'Souza, T. Kron, V. Venkatesan, D. Downey, R. Ash, and G. Bauman. 2003. Impact of urethrography on geometric uncertainty in prostate cancer radiotherapy. International Journal of Radiation, Oncology, Biology, Physics 57 (2 s): S331-332.

Videtic, G.M., L.W. Stitt, R.B. Ash, T. Truong, A.R. Dar, E.W. Yu, and F. Whiston. 2004. Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation. Lung Cancer 43 (2): 159-166.

BATTISTA, J.

Battista, J., and G.S. Bauman. 2003. The future of IMRT in INtensity-Modulted Radiation Therapy. Proceedings of AAPM Summer School. J.R. Palta, and T.R. Mackie. American Association of Physicists in Medicine.

Craig, T., J. Battista, and J. Van Dyk. 2003. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. I. The effect of shift invariance. Medical Physics 30 (8): 2001-2011.

Craig, T., J. Battista, and J. Van Dyk. 2003. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. II. The effect of a finite number of fractions. Medical Physics 30 (8): 2012-2020.

Craig, T., V. Moiseenko, J. Battista, and J. Van Dyk. 2003. The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. International Journal of Radiation, Oncology, Biology, Physics 57 (3): 833-842.

Kron, T., K. Jordan, and J. Battista. 2003. Tomotherapy Gel Images from London. COMP-CCPM Newsletter, Interactions 49 (3): 97.

Schaly, B., J.A. Kempe, G.S. Bauman, J.J. Battista, and D.J. Van. 2004. Tracking the dose distribution in radiation therapy by accounting for variable anatomy. Physics in Medicine & Biology 49 (5): 791-805.

Tai, P., E. Yu, J. Battista, and D.J. Van. 2004. Radiation treatment of lung cancer -- patterns of practice in Canada. Radiotherapy & Oncology 71 (2): 167-174.

BAUMAN, G.S.

Bauman, G., M. Fortin, J. Bissonnette, and J. Bahary. 2003. Radiotherapy for CNS Neoplasms: Principles, Technologies and Indications. Neurological Therapeutics: Principles and Practice. J. Noseworthy. New York: Martin-Dunitz Publishers. 676-687.

Bauman, G., E. Gete, JZ. Chen, and E. Wong. 2004. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy. Medical Dosimetry 29 (1): 18-25.

Bauman, G., and E. Shaw. 2003. Low Grade Glioma: Contemporary Management and Controversies. Hematology and Oncology 1 (9): 546-553.

Bauman, G.S., and J.P. Bahary. 2003. Radiation Therapy. Neurologic Therapeutics. J. Noseworthy. Cairncross: Martin-Dunitz Publishers. 672-687.

Roa, W., P.M. Brasher, G. Bauman, M. Anthes, E. Bruera, A. Chan, B. Fisher, D. Fulton, S. Gulavita, C. Hao, S. Husain, A. Murtha, K. Petruk, D. Stewart, P. Tai, R. Urtasun, JG. Cairncross, and P. Forsyth. 2004. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. Journal of Clinical Oncology 22 (9): 1583-1588.

Tai, P., and G. Bauman. 2003. Radiation of Chordomas and chondrosarcomas: photon irradiation. Chordomas and Chondrosarcomas of the Skull, Base and Spine. B. Ojemann, I. Janecka, H. Mankin, G. Harsh, and H. Suit (Eds.). New York: Thieme. 327-331.

Tai, P., and G.S. Bauman. 2003. Photon Irradiation. Chordomas and Chondrosarcomas of the skull base and spine. R.E. Ojemann, and et al. New York: Thieme Publishing. 299-306.

CHAMBERS, A.F.

Agrawal, D., T. Chen, R. Irby, J. Quakenbush, A.F. Chambers, M. Szabo, A. Cantor, D. Coppola, and T.J. Yeatman. 2003. Osteopontin identified as colon cancer tumor progression marker. Comptes Rendus Biologies 326 (10-11): 1041-1043.

Cadieux, P.A., D.T. Beiko, J.D. Watterson, J.P. Burton, J.C. Howard, B.E. Knudsen, B.S. Gan, J.K. McCormick, A.F. Chambers, J.D. Denstedt, and G. Reid. 2004. Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis . Journal of Clinical Laboratory Analysis 18 (3): 170-175.

Coppola, D., M. Szabo, D. Boulware, P. Muraca, M. Alsarraj, A.F. Chambers, and T.J. Yeatman. 2004. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clinical Cancer Research 10 (1 ): 184-190.

Ferguson, P.J., E. Kurowska, D.J. Freeman, A.F. Chambers, and D.J. Koropatnick. 2004. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. Journal of Nutrition 134 (6): 1529-1535.

Furger, K.A., A.L. Allan, S.M. Wilson, C. Hota, S.A. Vantyghem, C.O. Postenka, W. Al-Katib, A.F. Chambers, and A.B. Tuck. 2003. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin. Molecular Cancer Research 1 (11): 810-819.

Leali, D., P. Dell'Era, H. Stabile, B. Sennino, A.F. Chambers, A. Naldini, S. Sozzani, B. Nico, D. Ribatti, and M. Presta. 2003. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. Journal of Immunology 171 (2): 1085-1093.

Naumov, G.N., J.L. Townson, I.C. MacDonald, S.M. Wilson, V.H. Bramwell, A.C. Groom, and A.F. Chambers. 2003. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Research and Treatment 82 (3): 199-206.

Putnam, J.B., D. Royston, A.F. Chambers, S. Dunbar, J.H. Lemmer, P. Norman, E. Travis, A.A. Vaporciyan, S. Yang, and L.R. Zacharski. 2003. Evaluating the role of serine protease inhibition in the management of tumor micrometastases. Oncology (Huntingt) 17 (10 ): 9-30;31-32.

Rittling, S.R., and A.F. Chambers. 2004. Role of osteopontin in tumour progression. British Journal of Cancer 90 (10): 1877-1881.

Townson, J.L., G.N. Naumov, and A.F. Chambers. 2003. The role of apoptosis in tumor progression and metastasis. Current Molecular Medicine 3 (7): 631-642.

Vantyghem, S.A., C.O. Postenka, and A.F. Chambers. 2003. Estrous cycle influences organ-specific metastasis of B16F10 melanoma cells. Cancer Research 63 (16): 4763-5.

D'SOUZA, D.P.

Gien, L.T., J.S. Kwon, D.P. D'Souza, J.S. Radwan, J.A. Hammond, A.K. Sugimoto, and M.S. Carey. 2004. Brain metastases from endometrial carcinoma: a retrospective study. Gynecologic Oncology 93 (2): 524-528.

Rodrigues, G., D. D'Souza, J. Crook, S. Malone, J. Sathya, and G. Morton. 2003. Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists. Radiotherapy & Oncology 69 (1): 63-72.

Rodrigues, G., M. Lock, D. D'Souza, E.W. Yu, and J. Van Dyk. 2004. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer -- a systematic review. Radiotherapy & Oncology 71 (2): 127-138.

DAR, A.R.

Videtic, G.M., P.T. Truong, A.R. Dar, E.W. Yu, and LW. Stitt. 2003. Shifting from hypofractionated to conventionallyfractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation. International Journal of Radiation, Oncology, Biology, Physics 57 (3): 709-716.

DIMATTIA, G.E.

Paciga, M., C.R. McCudden, C. Londos, G.E. DiMattia, and G.F. Wagner. 2003. Targeting of big stanniocalcin and its receptor to lipid storage droplets of ovarian steroidogenic cells. Journal of Biological Chemistry 278 (49): 49549-49554.

FISHER, B.

HAMMOND, J.A.

Jackson, L.D., P.A. Groome, K. Schulze, B. O'Sullivan, J.C. Irish, P.F. Dixon, L.J. Eapen, S.P. Gulavita, J.A. Hammond, D.I. Hodson, R.G. Mackenzie, R.J. Bissett, K.M. Schneider, P.R. Warde, and W.J. Mackillop. 2003. Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada. Clinical Oncology (Royal College of Radiologists (Great Britain)) 15 (5): 266-279.

KOROPATNICK, D.J.

Haq, F., M. Mahoney, and J. Koropatnick. 2003. Signaling events for metallothionein induction. Mutation Research 533 (1-2): 211-226.

LOCK, M.

MOULIN, D.E.

Morley-Forster, P.K., A.J. Clark, M. Speechley, and D.E. Moulin. 2003. Attitudes toward opioid use for chronic pain: a Canadian physician survey. Pain Research Managament 8 (4): 189-194.

Russell, A., C.P. Watson, A.J. Clark, W. Arkinstall, D. Moulin, H. Hays, J. Eisenhoffer, P. Quigley, Z. Harsanyi, and A. Darke. 2003. Evaluation of dosing guidelines for use of controlled-release codeine in chronic noncancer pain. Pain Research Management 8 (3): 143-148.

Watling, C., and D. Moulin. 2003. Neuropathic Pain. Cancer Pain: Assessment and Management. E. Bruera, and R.K. Portenoy. Cambridge: Cambridge University Press. 396-407.

Watson, C.P., D. Moulin, J. Watt-Watson, A. Gordon, and J. Eisenhoffer. 2003. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105 (1-2): 71-78.

MYMRYK, J.S.

Bernat, A., N. Avvakumov, J.S. Mymryk, and L. Banks. 2003. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22 (39): 7871-7881.

Brown, K., Y. Chen, T.M. Underhill, J.S. Mymryk, and J. Torchia. 2003. The coactivator p/CIP/SRC-3 facilitates retinoic acid receptor signaling via recruitment of GCN5. Journal of Biological Chemistry 278 (41): 39402-39412.

Eskiw, CH., G. Dellaire, J.S. Mymryk, and D.P. Bazett-Jones. 2003. Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. Journal of Cell Science 116 (21): 4455-4466.

Holm, P.S., H. Lage, S. Bergmann, K. Jurchott, G. Glockzin, A. Bernshausen, K. Mantwill, A. Ladhoff, A. Wichert, J.S. Mymryk, T. Ritter, M. Dietel, B. Gansbacher, and H.D. Royer. 2004. Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy. Cancer Research 64 (1): 322-328.

Shuen, M., N. Avvakumov, J. Torchia, and J.S. Mymryk. 2003. The E1A proteins of all six human adenovirus subgroups target the p300/CBP acetyltransferases and the SAGA transcriptional regulatory complex. Virology 316 (1): 75-83.

Zhang, X., A.S. Turnell, C. Gorbea, J.S. Mymryk, P.H. Gallimore, and R.J. Grand. 2004. The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression. Journal of Biological Chemistry 279 (24): 25122-25133.

PERERA, F.

Perera, F., E. Yu, J. Engel, R. Holliday, L. Scott, F. Chisela, and V. Venkatesan. 2003. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. International Jounal of Radiation, Oncology, Biology, Physics 57 (5): 1239-1246.

RADWAN, J.S.

RODRIGUES, G.

SHERAR, M.D.

Davidson, S.R., and M.D. Sherar. 2003. Measurement of the thermal conductivity of polyacrylamide tissue-equivalent material. International Journal of Hyperthermia 19 (5): 551-562.

Kumaradas, J.C., and M.D. Sherar. 2003. Edge-element based finite element analysis of microwave hyperthermia treatments for superficial tumours on the chest wall. International Journal of Hyperthermia 19 (4): 414-430.

Pop, M., A. Molckovsky, L. Chin, M.C. Kolios, M.A. Jewett, and M.D. Sherar. 2003. Changes in dielectric properties at 460 kHz of kidney and fat during heating: importance for radio-frequency thermal therapy. Physics in Medicine & Biology 48 (15): 2509-2525.

Purdie, T.G., M.D. Sherar, and T.Y. Lee. 2003. The use of CT perfusion to monitor the effect of hypocapnia during laser thermal therapy in a rabbit model. International Journal of Hyperthermia 19 (4): 461-479.

Sherar, M.D., J. Trachtenberg, S.R. Davidson, C. McCann, C.K. Yue, M.A. Haider, and M.R. Gertner. 2003. Interstitial microwave thermal therapy for prostate cancer. Journal of Endourology 17 (8): 617-625.

TORCHIA, J.

TURLEY, E.A.

Tolg, C., R. Poon, R. Fodde, E.A. Turley, and B.A. Alman. 2003. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). Oncogene 22 (44): 6873-6882.

VAN DYK, J.

Chow, J.C., E. Wong, J.Z. Chen, and J. Van Dyk. 2003. Comparison of dose calculation algorithms with Monte Carlo methods for photon arcs. Medical Physics 30 (10): 2686-2694.

Mutic, S., J.R. Palta, E.K. Butker, I.J. Das, M.S. Huq, L.N. Loo, B.J. Salter, C.H. McCollough, J. Van Dyk, and No.66. AAPM Radiation Therapy Committee Task Group. 2003. Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM Radiation Therapy Committee Task Group No. 66. Medical Physics 30 (10): 2762-2792.

Tai, P., E. Yu, J. Battista, and D.J. Van. 2004. Radiation treatment of lung cancer -- patterns of practice in Canada. Radiotherapy & Oncology 71 (2): 167-174.

VENKATESAN, V.

WINQUIST, E.W.

Ernst, D.S., I.F. Tannock, E.W. Winquist, P.M. Venner, L. Reyno, M.J. Moore, K. Chi, K. Ding, C. Elliott, and W. Parulekar. 2003. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. Journal of Clinical Oncology 21 (17): 3335-3342.

Winquist, E.W., D.S. Ernst, D. Jonker, M.J. Moore, R. Segal, G. Lockwood, and A. Rodgers. 2003. Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract. European Journal of Cancer 39 (13): 1866-1871.

Winquist, E.W., T.S. Kirchner, R. Segal, J. Chin, H. Lukka, and Genitourinary Cancer Disease Site Group and Cancer Care Ontario Program in Evidence-based Care Practice Guidelines Initiative. 2004. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. Journal of Urology 171 (2. 1): 561-569.

WONG, E.

Gaede, S., and E. Wong. 2004. An algorithm for systematic selection of beam directions for IMRT. Medical Physics 31 (2): 376-388.

YEE, S.P.

Zou, M.X., D.T. Butcher, B. Sadikovic, T.C. Groves, S.P. Yee, and DI. Rodenhiser. 2004. Characterization of functional elements in the neurofibromatosis (NF1) proximal promotor region. Oncogene 23 (2): 330-339.

YU, E.W.

Tai, P., E. Yu, J. Battista, and D.J. Van. 2004. Radiation treatment of lung cancer -- patterns of practice in Canada. Radiotherapy & Oncology 71 (2): 167-174.

Tai, P., E.W. Yu, D. Skarsgard, and J. Tonita. 2003. Validation of the lognormal model for prediction of long-term survival rates from short-term follow-up study. Current Oncology 10 (3): 191-194.